Full Text
POB2 REDUCING GLOBAL CARDIOMETABOLIC RISK IN OVERWEIGHT OR OBESE INDIVIDUALS WITH DYSLIPIDEMIA- PROJECTED BENEFITS OF RIMONABANT IN A REAL WORLD POPULATION

Abstract

Authors

D Getsios J Moller P McEwan A Danel KJ Ishak JJ Caro

Back to Volume 10, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×